Biocrine Ab

Veit Flockerzi

Per-Olof Berggren

The present invention provides reagents and methods for identifying inhibitors of the L-type Cachannel &#x3b2;protein, which has been demonstrated to be involved in calcium signaling, insulin secretion, and glucose homeostasis. The invention also provides therapeutics and methods for treating a subject with one or more of diabetes, insulin resistance, impaired insulin secretion, and impaired glucose homeostasis, involving the use of inhibitors of an L-type Cachannel &#x3b2;subunit to provide a benefit to the subject.

Growing community of inventors

Munich, Georgia

Veit Flockerzi